Thursday, February 25, 2010
NC Biomedical Innovation Network Symposium RESCHEDULE
The North Carolina Biomedical Innovation Network, due to the greater-than-anticipated response to tomorrow's symposium, has decided to reschedule the program to be held at a later date in a larger local venue. This will enable everyone to attend the symposium who has expressed interest in it and will also lead to a more interactive program. Additionally, they are going to evaluate conducting an industry-wide symposium at a major scientific conference that will further showcase the extensive preclinical resources in North Carolina.
Live Feeds Disclaimer
The live feeds below are provided direct from the source, including public and private sector sources such as the FDA, Medical Product Manufacturing News, BioSpace, and Twitter Feeds.
The information provided from these feeds are not filtered for content by this blog, nor are they considered the opinion of this blog.
The information provided from these feeds are not filtered for content by this blog, nor are they considered the opinion of this blog.
MedCity News » North Carolina
- First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal
- How UNC Health Saved Over $5M On Annual Nurse Turnover Costs
- How Genome Sequencing Can Broaden the Scope of Newborn Screening
- While Auto vs. Allo Cell Therapy Debate Continues, VCs Look for ‘Next Shiny Thing’
- Precision Bio Offloads Lead Cell Therapy Program in Pivot to In Vivo Gene Editing
FDA's Center for Devices and Radiological Health
Error loading feed.
Medical Product Manufacturing News
Error loading feed.
BioSpace.com Featured News and Stories
- Ablynx Drug Fails Again in Mid-Stage Trial
- Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections
- ImmunoGen Stock Climbs on Positive Ovarian Cancer Data
- Stock Plunges Despite Biohaven's Positive Migraine Data
- Protagonist Craters After Discontinuing Phase IIb Ulcerative Colitis Study
BioSpace.com Career News
- ImmunoGen Stock Climbs on Positive Ovarian Cancer Data
- Stock Plunges Despite Biohaven's Positive Migraine Data
- Protagonist Craters After Discontinuing Phase IIb Ulcerative Colitis Study
- Ablynx Drug Fails Again in Mid-Stage Trial
- Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections
NC Medical - Twitter Search
Error loading feed.
Biomedical Engineering - Twitter Search
Error loading feed.
Medical Device - Twitter Search
Error loading feed.
Pharmaceutical - Twitter Search
Error loading feed.
Biologics - Twitter Search
Error loading feed.
FDA Drug Info - Twitter Feed
Error loading feed.